Clinical trials
Type 1 diabetes clinical trials
An autoimmune condition where the body makes little or no insulin. We’re tracking 875 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07297342Recruiting
Comparing ways to use the 'Get Ready' app for weight loss surgery
This study compares two ways of using a smartphone app called 'Get Ready' to help people follow their pre-surgery plan before weight loss surgery. It aims to see which approach helps patients stay on track better.
GeelAges Any age - NCT07304778Recruiting
Mobile app study for insulin dosing in type 1 diabetes
This trial tests a smartphone app that helps people with type 1 diabetes predict their blood sugar and decide how much insulin to take. It may be a good fit if you already use multiple daily insulin injections and a continuous glucose monitor.
Madrid, MadridAges 18–65 - NCT07317986Recruiting
Virtual peer support for type 1 diabetes in Canada
This study tests a customized virtual peer support program for people living with type 1 diabetes or other rare insulin-requiring forms of diabetes, as well as their loved ones. It aims to connect participants with others who understand their experiences and provide support remotely.
Québec, QuebecAges 18 years+ - NCT06791291RecruitingPhase 2
Teplizumab for Japanese with early-stage type 1 diabetes
This trial tests an experimental drug called teplizumab to see if it can slow down or stop type 1 diabetes from getting worse. It is for Japanese people aged 1 to 34 who have stage 2 type 1 diabetes (blood sugar is slightly abnormal but not yet full diabetes).
Ichikawa, ChibaAges 1–34 - NCT07348432Recruiting
Insulin delivery and eating behaviors in type 1 diabetes
This study looks at how different insulin delivery methods (like injections or pumps) affect eating behaviors in people with type 1 diabetes. By joining, you may help researchers learn how to improve care and quality of life.
Montreal, QuebecAges 12 years+ - NCT07356089Recruiting
Twiist insulin pump study for type 1 diabetes
This study follows people with type 1 diabetes who are already using the Twiist automated insulin delivery system. Researchers will ask you to complete surveys and share data for 12 months to check how well the system works in everyday life.
Tampa, FloridaAges 6 years+ - NCT07374328RecruitingPhase 1/Phase 2
Three diabetes medicines for new type 2 diabetes
This trial tests a combination of three diabetes medicines to see if they can quickly get high blood sugar under control in people newly diagnosed with type 2 diabetes. It's designed for those whose HbA1c is 9.0% or higher.
Guangzhou, GuangdongAges 18–65 - NCT07374705Recruiting
Brain insulin resistance and health in diabetes
This study looks at how insulin resistance in the brain affects brain health. If you have type 1 or type 2 diabetes and are between 50 and 80 years old, you may be able to join to help researchers understand brain changes.
Glostrup MunicipalityAges 50–80 - NCT07386340Recruiting
Testing a new continuous glucose monitor with flash readings
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
Escondido, CaliforniaAges 18 years+ - NCT01055093Recruiting
Study of diabetes complications in adults soon after diagnosis
This study follows adults who have been diagnosed with diabetes recently to better understand diabetes and its complications over time. It also includes a comparison group of people who do not have diabetes to help researchers see what changes are linked to diabetes.
Düsseldorf, North Rhine-WestphaliaAges 18–69 - NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age - NCT01630850Recruiting
Islet cell transplant for brittle type 1 diabetes
This trial studies whether transplanting insulin-producing islet cells can improve blood sugar control and reduce severe low blood sugar in people with “brittle” type 1 diabetes. It’s meant for adults with long-standing insulin dependence and troublesome, hard-to-control hypoglycemia.
Chicago, IllinoisAges 18–70 - NCT01241864RecruitingPhase 2
Islet transplant for type 1 diabetes after kidney transplant
This trial tests whether transplanting insulin-producing “islet” cells can better control blood sugar in people who have already received a kidney transplant. It’s mainly for adults with type 1 diabetes whose body is no longer making enough insulin, while they are on kidney-transplant medicines.
Chicago, IllinoisAges 18–68 - NCT02306005Recruiting
Study insulin effects on blood fats in new type 1 diabetes
This study looks at how starting insulin soon after type 1 diabetes begins affects the body’s “blood fats” (lipoproteins). It may help researchers understand whether insulin changes these levels in early disease.
PoznanAges 18–35 - NCT02734277Recruiting
Extending a past Type 1 diabetes immune study
This study is for people who already took part in an earlier immune-tolerance program for Type 1 diabetes. It tests whether continuing follow-up and assessments can be done safely and may help learn more about long-term immune effects of treatment.
San Francisco, CaliforniaAges 8–35 - NCT03369821Recruiting
Study of immune changes in very early childhood type 1 diabetes
This study looks at immune system cells and gene activity in infants and young children to understand what causes type 1 diabetes to start so early. It may help researchers find earlier warning signs and better ways to support families right at diagnosis.
Seattle, WashingtonAges Up to 70 years - NCT07676565Recruiting
Adding new drugs to insulin for type 1 diabetes
This study tests whether adding certain diabetes pills (GLP-1 receptor agonists or SGLT inhibitors) to insulin is safe and helpful for adults with type 1 diabetes. Doctors will check your glucose monitor data to see how well this works.
Newport Beach, CaliforniaAges 18 years+ - NCT06897904Recruiting
Blood and clotting tests in type 1 diabetes kids
This study looks at blood cell counts and clotting function in children with type 1 diabetes. It aims to find any changes that might be related to diabetes, which could help with better monitoring and care.
Asyut, Asyut GovernorateAges Up to 18 years - NCT01779115Enrolling by invitation
Diabetes registry for people with diagnosed high blood sugar
This is a research registry that collects information from people who have diabetes (high blood sugar on tests or based on diabetes treatment). It may help researchers understand diabetes patterns in a real-world healthcare system.
Tel AvivAges Any age - NCT07409701Recruiting
Gamification help for kids with type 1 diabetes
This study tests if a game-based app helps children aged 8 to 12 manage their type 1 diabetes better. It could make learning about diabetes more fun and engaging.
Ankara, YenimahalleAges 8–12 - NCT07416656Recruiting
Checking blood sugar test accuracy for arthritis patients on sulfasalazine
This study checks if the medicine sulfasalazine affects a blood sugar test (HbA1c) in people with inflammatory arthritis. If you have arthritis, take sulfasalazine, and have higher blood sugar or diabetes, this trial may help understand your glucose levels.
Silkeborg, Central JutlandAges 18 years+ - NCT07427134Recruiting
Insulin dose calculator app for type 1 diabetes in children
This study tests a new insulin dose calculator app for children under 12 with type 1 diabetes who use daily insulin shots and already count carbs.
MosulAges 1–12 - NCT07433257Recruiting
Steroid injection for carpal tunnel with diabetes
This study tests if a steroid injection in the wrist helps people with carpal tunnel syndrome, comparing results between those with and without type 2 diabetes. If you have mild to moderate carpal tunnel and either well-controlled diabetes or no diabetes, you may be able to join.
Istanbul, IstanbulAges 18–75 - NCT07434154Recruiting
Comparing oxidative stress in type 1 diabetes and LADA
This study looks at oxidative stress—a type of cell damage—in people with type 1 diabetes or LADA. It may help explain how these conditions affect the body and guide future care.
Pavia, PaviaAges 18–75
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes?
- Yes. Clin2 currently lists 875 recruiting type 1 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.